Illumina Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
/ 
Frequently asked questions
To buy Illumina Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Illumina Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Illumina Inc. is ILMN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Illumina Inc. has its primary listing on NASDAQ. You can trade Illumina Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Illumina Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Illumina Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Illumina Inc..